Medicamen Biotech Limited (MEDICAMEQ)
₹411.3
INR+1.65(+0.40%)
As of June 17, 2025 9:36:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹560.35 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹550.35 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
79.39
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
-1.97
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
3.45
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
53.52%
Operating Margin
Operating income as a percentage of revenue
-7.05%
Return on Equity
Net income as a percentage of shareholders' equity
3.12%
Revenue (TTM)
Total revenue over trailing 12 months
₹162.55 Cr-37.4%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹20.10 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹5.16-12.4%
Balance Sheet
Total Cash
Total cash and short-term investments
₹3.76 Cr
Total Debt
Total short-term and long-term debt
₹33.25 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
15.63%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹375.05 - ₹630
Beta
Measure of stock's volatility compared to the market
1.03
Shares Outstanding
Total number of shares issued by the company
₹1.27 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
83.63%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
20.91%
Payout Ratio
Percentage of earnings paid as dividends
19.38%
